Product Code: ETC070003 | Publication Date: Jun 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The contract cell and gene therapy manufacturing market in India is expected to witness significant growth over the forecast period due to increasing investments by government bodies, academic institutes, and private players towards developing advanced treatments for cancer. The industry also benefits from the abundance of qualified talent available in the country combined with a favourable regulatory framework that enables access to diverse raw materials at competitive prices.
Government Initiatives: In recent years, there has been an increase in government initiatives aimed at fostering research activity related to cell and gene therapies in India. This includes investment of funds into setting up new laboratories and providing grants to further develop innovative products using local resources. Growing Awareness about Cell & Gene Therapies: There is an increased awareness among Indian consumers regarding the potential benefits offered by cell and gene therapy products for treating various ailments such as cancer, HIV/AIDS, etc., which is likely to drive demand for these services across the country over the coming years. Increasing Market Size, India?s contract cell & gene therapy manufacturing market was estimated at ~$X Mn in 2025 and is projectedto reach ~$Y Mn by 2031 growing at a CAGR of X%. This can be attributed mainly due to rising incidence rates of chronic diseases along with increasing prevalence of lifestyle-related disorders such as obesity that are being treated through modern therapeutic approaches like stem cells or viruses carrying genetic material across Indian healthcare system .
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Contract Cell and Gene Therapy Manufacturing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 India Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 India Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2021 & 2031F |
3.6 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 India Contract Cell and Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Contract Cell and Gene Therapy Manufacturing Market Trends |
6 India Contract Cell and Gene Therapy Manufacturing Market, By Types |
6.1 India Contract Cell and Gene Therapy Manufacturing Market, By Vector |
6.1.1 Overview and Analysis |
6.1.2 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2018 - 2031F |
6.1.3 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2018 - 2031F |
6.1.4 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2018 - 2031F |
6.2 India Contract Cell and Gene Therapy Manufacturing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2018 - 2031F |
6.2.3 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2018 - 2031F |
6.2.4 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2018 - 2031F |
6.2.5 India Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2018 - 2031F |
7 India Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 India Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries |
7.2 India Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries |
8 India Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators |
9 India Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 India Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2021 & 2031F |
9.2 India Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 India Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 India Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 India Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |